Downloading...
Download
WULF / 3hNASDAQ:WULF According to the bearish alternative in my weekly frame (not the chart below and not posted recently), the entire countertrend rally, which has developed in an ABC zigzag sequence as anticipated in the analysis which I posted on May 12, may have reached a very late stage where an adjusted expanding diagonal as the thorough Minor degree wave C remains at the start point of a final advance as its 5th subdivision. It will conclude the entire correction upward since April 9. NASDAQ:WULF 's Bearish Alternative : Wave Analysis >> As depicted on this 3h-frame above, the structure of the entire countertrend advance, which has developed since April 9, may be considered in a thorough ABC zigzag correction, in which Minor degree wave C should have diagonally reached its very late stage now. It would likely achieve its expansion target >> 5.55. And it would be a 170% gain of a countertrend rally at the end!! Now, 8.6% of the advance remains to complete a possible ending expanding diagonal upward as the Minor degree wave C. Trend Analysis  >> The countertrend upward as Intermediate degree wave (B) will probably change to decline in the same degree wave (C) very soon!! And it'll likely last until the end of the year. #CryptoStocks #WULF #BTCMining #Bitcoin #BTC NASDAQ:WULF CRYPTOCAP:BTC MARKETSCOM:BITCOIN
NASDAQ:WULF
by ElliottChart
LDOS LONG🚀 NYSE:LDOS – Breakout Setup After Months of Accumulation NYSE:LDOS is showing a high-conviction breakout setup after six months of tight accumulation. Here's what I'm seeing: 🔹 Flagging on the 8EMA with low volume – classic bullish continuation 🔹 Clean structure with higher lows and controlled pullbacks 🔹 Volume drying up during the recent consolidation = potential energy building 🔹 Breakout in progress with RSI staying strong but not overbought 🔹 Accumulation range forming a solid launchpad 📈 With earnings due Aug 5 (BMO) and strong fundamental backing, I expect volume to come in soon and fuel the next leg higher. 🟢 Targets: $184 short-term $211 by year-end 🔴 Stop: $159 – below the accumulation base and prior support zone Why I Like It: ✅ EPS growth +325% YoY ✅ Forward P/E only 14.1 ✅ Strong ROE (31%) + institutional accumulation ✅ Momentum without overextension ✅ Positioned in a defensive-growth sector with macro tailwinds (defense, cybersecurity, AI) 📊 Looks like smart money has been accumulating – and it's almost time to move.
NYSE:LDOSLong
by SPYDERMARKET
The key is whether it can be supported and rise near 300.17 Hello, traders. If you "Follow", you can always get new information quickly. Have a nice day today. ------------------------------------- (MCD 1D chart) Before following the basic trading strategy, the first thing to check is whether the current price is above or below the M-Signal indicator on the 1M chart. If the price is below the M-Signal indicator on the 1M chart, there is a possibility that it will turn into a medium- to long-term downtrend. Therefore, if possible, it is recommended to trade stocks whose prices are above the M-Signal indicator on the 1M chart. If the price is below the M-Signal indicator on the 1M chart, you should respond quickly and briefly using the short-term trading (day trading) method. - The support and resistance zones can be seen as the 287.46-290.14 zone and the 307.41-314.89 zone. The 287.46-290.14 zone is the DOM(-60) ~ HA-Low zone, and the 307.41-314.89 zone is the HA-High ~ DOM(60) zone. These two zones are likely to form a trend depending on how they break through, so they can be seen as support and resistance zones. - The 300.17-316.56 zone is the HA-High ~ DOM(60) zone on the 1W chart. Therefore, we need to check whether it can receive support and rise in the 300.17-316.56 zone. Therefore, if it falls near the 307.41-314.89 range, you should check for support near 300.17. - If it rises above the HA-High ~ DOM(60) range, it is likely to show a step-up trend, and if it falls in the DOM(-60) ~ HA-Low range, it is likely to show a step-down trend. - Thank you for reading to the end. I hope you have a successful transaction. --------------------------------------------------
NYSE:MCD
by readCrypto
KULR Daily Watch – Triangle Squeeze Loading📍 Price Action: Sitting tight at $6.50, coiling inside a clean symmetrical triangle. Last fake-out under support didn’t confirm → bulls still holding the line. 📊 Pattern Probabilities (Bulkowski): Symmetrical triangles break ~54–60% in trend direction. Post-breakout moves hit ~60–75% of measured height → decent odds for upside here. ✅ Volume contracting = typical pre-breakout behavior ✅ RSI divergence still bullish ✅ Channel since 2023 intact, macro structure supports trend-following 🎯 Targets & RR Setup: Trigger zone: $7.20–$7.50 Target 1: $9.45 (+31% | RR ~2.5:1) Target 2: $28.81 (+298% | RR ~12:1) Target 3 (channel top): $168.12 (+2,368% | moonshot 🌙) ⏳ Next Step: Break over $7.50 = green light for Target 1. We’re trailing stops below the rising trendline to lock in gains without killing the move early. #KULR #TrianglePattern #BreakoutWatch #TargetTraders #StockMarket
AMEX:KULRLong
by TargetTraders
MRK Wave Analysis – 14 July 2025- MRK reversed from the support zone - Likely to rise to resistance level 85.00 MRK recently reversed up from the support zone surrounding the long-term support level 73.45 (which has been reversing the price from the start of 2020, as can be seen from the weekly MRK chart below). The upward reversal from the support level 73.45 started the active long-term impulse wave III. MRK can be expected to rise to the next resistance level 85.00 (former top of wave (4) from May) – from where the price is likely to correct down.
NYSE:MRKLong
by FxProGlobal
PALANTIR REMAINS YOUR TRADING GOAL, DOUBLING IN PRICE IN 2025In the Faraway Kingdom... In the Thirtieth Realm.... Somewhere in another Galaxy.. in late December, 2024 (yet before The Second Coming of Trump), @TradingView asked at it awesome Giveaway: Happy Holidays & Merry Christmas . 1️⃣ What was your best trade this year? 2️⃣ What is your trading goal for 2025? Here's what we answered: 1️⃣ What was your best trade this year? - Surely Palantir NASDAQ:PLTR 💖 I followed Palantir all the year since January, 2024, from $16 per share, watch here . Current result is 5X, to $80 per share. Also I added more Palantir after SP500 Index inclusion in September 2024 watch here . Current result is 2.6X, from $30 to $80 per share. 2️⃣ What is your trading goal for 2025? - Once again, surely Palantir NASDAQ:PLTR 💖 It's gone 7 months or so... (Wow... 7 months really? 😸😸😸) Let see what's happened next at the main graph of Palantir stock, to LEARN WHY PALANTIR REMAINS THE TRADING GOAL, DOUBLING IN PRICE IN 2025... Palantir stock remains an attractive trading goal for several compelling reasons rooted in its strong market performance, innovative technology, and robust growth prospects, particularly in the artificial intelligence (AI) sector. 1. Exceptional Stock Performance and Momentum. Palantir Technologies has been one of the best-performing stocks in 2025, surging over 80% in the first half of the year alone, vastly outperforming the S&P 500’s modest 5.5% gain. The stock recently hit all-time highs around $149, reflecting a nearly 400% increase year-over-year, underscoring its strong momentum and investor enthusiasm. This surge positions Palantir as a top AI stock to watch, attracting both retail and institutional investors, including conservative entities like the Czech National Bank. 2. Leadership in AI and Data Analytics. Palantir is not just a data analytics company; it has transformed into a major AI software provider with its Artificial Intelligence Platform (AIP). This platform extends beyond government contracts into commercial sectors such as healthcare, energy, and automotive, fueling significant revenue growth. The company reported a 39% revenue increase to $883.9 million in Q1 2025, driven largely by AI adoption. Its AI platform is gaining traction globally, with many companies rapidly adopting Palantir’s software through short training bootcamps, demonstrating scalable and fast integration. 3. Strong Government and Commercial Contracts. Palantir’s roots in government intelligence and defense continue to be a significant revenue driver. The U.S. government division alone generated $373 million in Q1 2025, with overall government revenue up 45% year-over-year. Strategic partnerships, such as with Accenture to streamline federal operations and projects like the U.S. Navy’s ‘Warp Speed for Warships,’ highlight Palantir’s expanding footprint in critical government sectors. Simultaneously, the commercial segment is booming, with revenue soaring 71% to $255 million in Q1 and projected to reach $1.178 billion in 2025. 4. Financial Health and Growth Outlook. Palantir’s financials are strengthening, with no debt and adjusted free cash flow more than doubling to $370.4 million in the recent quarter. Analysts forecast the company’s revenue to exceed $3.5 billion in 2025, up from $2.23 billion the previous year, and project potential revenue of $7 billion by 2028. Operating margins are improving, with a recent quarter reporting a 26% margin, the highest in company history. This solid financial foundation supports further investment in AI innovation and market expansion. 5. Market Position and Competitive Edge. While Palantir competes with tech giants like Microsoft, Amazon, and Google in the AI and data analytics space, it has carved out a unique niche with its specialized government contracts and AI-driven software solutions. Its ability to integrate complex datasets for real-world operational use distinguishes it from competitors, fostering a loyal investor base and a "cult-like" following among retail investors. 6. High Valuation Reflects Growth Expectations. Despite a high price-to-earnings ratio (PE around 621), reflecting elevated expectations, many analysts remain optimistic about Palantir’s long-term potential due to its rapid growth and expanding AI capabilities. The company’s market capitalization has soared above $330 billion, surpassing many established corporations, signaling strong market confidence. 7. Palantir stock is a compelling trading goal because it combines robust growth, cutting-edge AI technology, strong government and commercial contracts, and solid financial health. 8. In conclusion, Palantir remarkable stock performance and strategic positioning in the booming AI sector make it a promising investment for traders seeking exposure to transformative technology with significant upside potential. 9. ...and yet, Palantir performance since inception (It ultimately went public on the New York Stock Exchange through a direct public offering on September 30, 2020) is better, rather then Bitcoin. -- Best wishes, @PandorraResearch Team 😎
NASDAQ:PLTR
by PandorraResearch
KHC – Momentum Reversal with Volume Surge & Tactical Exit Plan📈 Ticker: NASDAQ:KHC (The Kraft Heinz Company – NASDAQ) 📆 Timeframe: 1D (Daily) 💵 Current Price: $27.80 📊 Pattern: Falling Wedge Breakout + Volume & RSI Divergence 📌 Trade Setup: ✅ Our Entry: $26.60 ⛔ Stop-Loss: Below $24.80 🔰 Confirmation Signals: Bullish volume divergence: Selling pressure diminished while price made lower lows Explosive green volume bar on breakout — strongest in 12+ months RSI breakout above 60, confirming strong momentum and trend shift 💰 Profit-Taking Strategy: 📍Sell Zone Price Level % of Position Rationale 🥇 Sell 1 $28.48 50% Pre-earnings resistance – lock early profit 🥈 Sell 2 $30.71 30% Next strong resistance area 🥉 Sell 3 $31.62 10% Long-term descending trendline — potential reversal point 🔄 Remaining 10%: Optional trail with stop-loss raised, if momentum continues 📊 Technical Confidence & Probabilities: 🧠 Pattern: Falling Wedge Bulkowski probability of breakout upward: ~68% Average gain post-breakout: ~38%, though current targets are more conservative (15–19%) 📈 Volume breakout + prior divergence = strong institutional signal 📉 Risk clearly defined with stop at $24.80 📈 Target Gains vs Entry ($26.60): 🎯 Target Price Gain from Entry Target 1 $28.48 +7.06% Target 2 $30.71 +15.47% Target 3 $31.62 +18.89% 🧾 Summary: This is a high-probability breakout play, combining: ✅ Bulkowski-validated falling wedge ✅ Volume-based confirmation ✅ Clear stop and tiered exit strategy ✅ Strong risk/reward profile “Our Entry Price: $26.60 – Breakout Backed by Big Money” #KHC #TargetTraders #VolumeSpike #BreakoutTrade #TechnicalAnalysis #Bulkowski #StockMarket #Investing
NASDAQ:KHCLong
by TargetTraders
TSLA - Explosive Bounce TSLA Before the Drop? | EW Analysis My primary view is that we’re in the final stages of an ending diagonal, which could lift the price to new all-time highs, potentially between $460 and $650. Wave 4 of this structure appears to have completed after precisely tagging key Fibonacci support, and since then, we've already seen a strong bounce from that low. I’m now watching for the development of the final wave in this pattern, which could deliver gains of over 100% from current levels. However, I’m not fully convinced by the internal shape of the diagonal so far. That’s why I’m also have an alternative scenario: in this case, the recent low may have marked the end of Wave 2 within a much larger diagonal. If true, this opens the door to a much more extended rally potentially reaching $1,000 before we see a major correction. That said, this second scenario is not my preferred one, and a decisive break below the recent lows would invalidate both counts.
NASDAQ:TSLALong
by UnbieY
UMAC To the Moon The daily chart of Unusual Machines, Inc. (UMAC) reinforces a bullish breakout continuation setup, A Bullish flag within its rising channel . 🧠 Technical Highlights Initial Surge: The stock launched from consolidation to a high near $24.00 in late 2024, gaining +1,737% during the move. Consolidation Phase: The price corrected within a bull flag/descending channel structure (highlighted in red), followed by a breakout above channel resistance. Breakout & Retest: Price broke out above the $7.80 resistance zone, tested it, and bounced — confirming support conversion. Current price: $11.60. 📏 Measured Move & Channel Analysis Measured Move: Using the height of the initial rally (22.42 points) and projecting from the breakout zone ($7.80), a bullish price target of $143.34 is calculated — a 1,735% upside. Bullish Regression Channel: A broader green ascending channel suggests the long-term trend structure remains intact and price may climb along the mid- to upper-channel lines. 📌 Key Resistance Levels Zone Price Notes Local Resistance $21.50–$23.68 Former high area from late 2024 Psychological Levels $50 / $100 Round-number zones where traders often react Optimism/Bull Trap Zone $142.99 Target area where parabolic move may exhaust ✅ Validation Checklist ✔ Breakout above flag/channel with increasing volume ✔ Successful retest of breakout zone (~$7.80) ✔ Trend confirmation with higher highs and volume spike ✔ Clear structure supporting measured move thesis 🧭 Strategy Thoughts Entry Confirmation: Ideal entry occurred around the breakout/retest near $7.80–$9.00 Risk Management: Protective stop could be placed under $7.00 if newly initiated Profit Zones: Consider scaling out at $23, $50, $100, and holding a moonshot tranche toward $143 Current market cap = 230M . A surge to estimated levels would bring this stock up to 5B.
AMEX:UMACLong
by HernandezCapital
2
APPLE Set To Fall! SELL! My dear friends, APPLE looks like it will make a good move, and here are the details: The market is trading on 211.08 pivot level. Bias - Bearish Technical Indicators: Supper Trend generates a clear short signal while Pivot Point HL is currently determining the overall Bearish trend of the market. Goal - 206.69 Recommended Stop Loss - 213.91 About Used Indicators: Pivot points are a great way to identify areas of support and resistance, but they work best when combined with other kinds of technical analysis Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. ——————————— WISH YOU ALL LUCK
NASDAQ:AAPLShort
by AnabelSignals
1
KURA Set for Liftoff: Breakthrough Cancer Drug, Massive Analyst Kura Oncology (KURA) is emerging from a prolonged downtrend just as its lead drug candidate, ziftomenib, approaches a critical FDA decision deadline this fall. With zeroed-in focus on targeted leukemia treatments and no approved competitors in its niche, Kura is positioned to benefit from increasing demand for precision oncology therapies and growing biotech investment. Wall Street analysts remain highly optimistic, projecting more than 300% upside based on Kura’s strong cash position, late-stage pipeline, and potential blockbuster market for its lead asset. In a healthcare landscape where next-generation cancer treatments are both a clinical and economic priority, Kura’s story stands out as a high-reward opportunity for long-term investors. Don’t miss our next big setup—hit follow now!
NASDAQ:KURALong
by NinjaCodeSolutions